Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial).
暂无分享,去创建一个
Deepak L. Bhatt | S. Steinhubl | E. Topol | M. Shao | P. Steg | K. Fox | G. Montalescot | K. Mak | P. Berger | A. Dimas | Michael A. Weber | S. Haffner | Arijit Dasgupta | P. G. Steg | M. Weber